U S Physical Therapy SEC Filings

US Physical Therapy, Inc. (USPH) reported a proposed sale of 1,000 common shares through Rule 144 to be executed on 09/05/2025 on the NYSE via Morgan Stanley Smith Barney LLC. The shares were acquired on 07/01/2024 under the company's Employee Stock Purchase Plan and were paid as compensation. The notice lists an aggregate market value of $85,250.00 for the shares and shows 15,204,119 shares outstanding for the issuer. The filer certifies they are unaware of undisclosed material adverse information and indicates no reportable securities sales in the past three months.

US Physical Therapy, Inc. (USPH) submitted a Form 144 notifying a proposed sale of 2,000 shares of common stock through UBS Financial Services on the NYSE with an aggregate market value of $165,127.20. The shares were originally acquired as restricted stock grants on 04/01/2020 (3,089 shares acquired) and were paid as compensation on the acquisition date. The filing states there were no securities sold by the reporting person in the past three months. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.

US Physical Therapy Inc. (USPH) Chief Financial Officer Carey P. Hendrickson reported a disposal of 698 shares of common stock on 08/25/2025 at an average price of $86.11 per share, leaving beneficial ownership of 27,808 shares. The filing shows Mr. Hendrickson is an officer (Chief Financial Officer) and the Form 4 was filed by one reporting person.

The reported holdings include 14,510 shares issued as restricted stock under the companys Amended and Restated 2003 Stock Incentive Plan. Those restricted shares vest in scheduled tranches from November 20, 2025 through March 6, 2029, contingent on continued employment, with specific share counts and vesting dates provided in the filing.

US Physical Therapy, Inc. (USPH) filed a Form 144 proposing the sale of 700 shares of common stock through Charles Schwab & Co., Inc. The filing lists an approximate sale date of 08/25/2025 and reports an aggregate market value of $60,119. It shows total shares outstanding of 15,204,119, indicating the proposed sale represents a very small fraction of the companys outstanding stock. The shares were acquired on 01/01/2025 as employee equity compensation (1,208 shares reported acquired). The filer reports no sales in the past three months.

US Physical Therapy, Inc. insider sale reported. The company's COO and director, Graham D. Reeve, reported the sale of 763 shares of Common Stock on 08/21/2025 at a weighted average price of $84.97 per share. After the sale he beneficially owns 21,483 shares directly and 1,808 shares indirectly through the Reeve Trust. The filing notes that 15,296 of his shares are restricted stock with a detailed vesting schedule from November 2025 through March 2029.

US Physical Therapy, Inc. (USPH) Form 144 notifies the planned sale of 763 shares of Class A Common Stock by Graham Reeve through J.P. Morgan Securities on or about 08/21/2025, with an aggregate market value listed as $64,832. The shares were acquired on 05/20/2025 through the vesting of restricted stock grants issued between 08/16/2021 and 02/24/2025. The filing shows the person intends cash payment on 08/22/2025. The issuer’s outstanding shares are reported as 15,190,000, making this sale a very small portion of total stock. The filing also discloses two prior sales by the same person within the past three months: 1,792 shares on 08/11/2025 for $155,124.48 and 530 shares on 05/21/2025 for $41,382. The signer represents they are not aware of undisclosed material adverse information about the issuer.

Richard Binstein, Executive Vice President, General Counsel & Secretary of U S Physical Therapy, Inc. (USPH), reported the sale of 2,000 shares of the issuer's common stock on 08/19/2025 at a price of $84.79 per share. After the sale he beneficially owned 17,867 shares. The filing discloses that 15,726 of those shares were granted as restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan and lists the detailed vesting schedule showing incremental lapses from August 20, 2025 through March 6, 2029, contingent on continued employment on each vesting date. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.

US Physical Therapy Inc (USPH) filed a Form 144 notifying a proposed sale of 2,000 Class A common shares through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $169,570.50. The filing shows those shares were acquired by the seller through vesting of restricted stock awards granted between 8/16/2021 and 2/24/2025, received in three vesting events on 7/01/2024 (1,045 shares), 10/01/2024 (305 shares), and 1/01/2025 (650 shares). The proposed approximate date of sale is 08/19/2025. The filer certifies they are not aware of undisclosed material adverse information about the issuer.

Three institutional filers disclosed beneficial ownership of US Physical Therapy ordinary shares. Kayne Anderson Rudnick Investment Management, LLC reports beneficial ownership of 1,486,334 shares, representing 9.8% of the class. Virtus Investment Advisers, LLC reports 1,042,658 shares (6.9%) and Virtus Equity Trust on behalf of Virtus KAR Small-Cap Growth Fund reports 975,582 shares (6.4%).

The filing details voting and dispositive power: Kayne Anderson reports 417,216 shares with sole voting power and 443,348 shares with sole dispositive power, with larger amounts held in shared voting/dispositive arrangements. The filing also certifies the shares are held in the ordinary course of business and not to influence control, and notes that amounts reported for the Virtus entities are included in the amounts reported by Kayne Anderson Rudnick on this Schedule 13G.